These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 10961468)

  • 1. Urinary phytate in calcium oxalate stone formers and healthy people--dietary effects on phytate excretion.
    Grases F; March JG; Prieto RM; Simonet BM; Costa-Bauzá A; García-Raja A; Conte A
    Scand J Urol Nephrol; 2000 Jun; 34(3):162-4. PubMed ID: 10961468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
    Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
    Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the Potential Relationship Between Phytate Ingestion, Urinary Phytate Excretion, and Renal Stone Risk in a Unique Human Model: No Hard Evidence in Support of Phytate as a Stone Inhibitor.
    Fakier S; Rodgers A
    J Ren Nutr; 2020 Sep; 30(5):396-403. PubMed ID: 31928801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary lithogen risk test: usefulness in the evaluation of renal lithiasis treatment using crystallization inhibitors (citrate and phytate).
    Conte A; Pizá P; García-Raja A
    Arch Esp Urol; 1999; 52(1):94-9. PubMed ID: 10101897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in urinary risk profile after short-term low sodium and low calcium diet in recurrent Swiss kidney stone formers.
    Seeger H; Kaelin A; Ferraro PM; Weber D; Jaeger P; Ambuehl P; Robertson WG; Unwin R; Wagner CA; Mohebbi N
    BMC Nephrol; 2017 Dec; 18(1):349. PubMed ID: 29202723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary lithogen risk test: usefulness in the evaluation of renal lithiasis treatment using crystallization inhibitors (citrate and phytate).
    Conte A; Pizá P; García-Raja A; Grases F; Costa-Bauzá A; Prieto RM
    Arch Esp Urol; 1999 Apr; 52(3):305-10. PubMed ID: 10371752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phytate acts as an inhibitor in formation of renal calculi.
    Grases F; Isern B; Sanchis P; Perello J; Torres JJ; Costa-Bauza A
    Front Biosci; 2007 Jan; 12():2580-7. PubMed ID: 17127264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of inositol hexaphosphate (phytate) on calcium binding, calcium oxalate crystallization and in vitro stone growth.
    Saw NK; Chow K; Rao PN; Kavanagh JP
    J Urol; 2007 Jun; 177(6):2366-70. PubMed ID: 17509360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diet and renal stone formation.
    Trinchieri A
    Minerva Med; 2013 Feb; 104(1):41-54. PubMed ID: 23392537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of dietary intake on urinary oxalate excretion in calcium oxalate stone formers in their forties.
    Naya Y; Ito H; Masai M; Yamaguchi K
    Eur Urol; 2000 Feb; 37(2):140-4. PubMed ID: 10705190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulatory effect of the 23-kD calcium oxalate monohydrate binding protein on calcium oxalate stone formation during oxalate stress.
    Asokan D; Kalaiselvi P; Varalakshmi P
    Nephron Physiol; 2004; 97(1):p23-30. PubMed ID: 15153748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperoxaluria in patients with recurrent calcium oxalate calculi: dietary and other risk factors.
    Laminski NA; Meyers AM; Kruger M; Sonnekus MI; Margolius LP
    Br J Urol; 1991 Nov; 68(5):454-8. PubMed ID: 1747716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pathophysiology, diagnosis and conservative therapy in calcium kidney calculi].
    Hess B
    Ther Umsch; 2003 Feb; 60(2):79-87. PubMed ID: 12649986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of diet on urinary risk factors for stones in healthy subjects and idiopathic renal calcium stone formers.
    Trinchieri A; Mandressi A; Luongo P; Longo G; Pisani E
    Br J Urol; 1991 Mar; 67(3):230-6. PubMed ID: 2021806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystallization properties in urine from calcium oxalate stone formers.
    Tiselius HG; Bek-Jensen H; Fornander AM; Nilsson MA
    J Urol; 1995 Sep; 154(3):940-6. PubMed ID: 7637098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nutritional aspects of stone disease.
    Hess B
    Endocrinol Metab Clin North Am; 2002 Dec; 31(4):1017-30, ix-x. PubMed ID: 12474643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Excessive crystal agglomeration with low citrate excretion in recurrent stone-formers.
    Kok DJ; Papapoulos SE; Bijvoet OL
    Lancet; 1986 May; 1(8489):1056-8. PubMed ID: 2871335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium oxalate monohydrate binding protein: a diagnostic biomarker for calcium oxalate kidney stone formers.
    Asokan D; Kalaiselvi P; Muhammed Farooq S; Varalakshmi P
    Urol Res; 2004 Oct; 32(5):357-61. PubMed ID: 15365653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simple dietary advice targeting five urinary parameters reduces urinary supersaturation in idiopathic calcium oxalate stone formers.
    Sromicki J; Hess B
    Urolithiasis; 2020 Oct; 48(5):425-433. PubMed ID: 32524204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical and dietary factors of uric acid stone formation.
    Trinchieri A; Montanari E
    Urolithiasis; 2018 Apr; 46(2):167-172. PubMed ID: 28246885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.